CN220293854U - Hard capsule with gastric mucosa protecting function - Google Patents
Hard capsule with gastric mucosa protecting function Download PDFInfo
- Publication number
- CN220293854U CN220293854U CN202321225054.9U CN202321225054U CN220293854U CN 220293854 U CN220293854 U CN 220293854U CN 202321225054 U CN202321225054 U CN 202321225054U CN 220293854 U CN220293854 U CN 220293854U
- Authority
- CN
- China
- Prior art keywords
- capsule
- shell
- inner shell
- gastric mucosa
- outer shell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001156 gastric mucosa Anatomy 0.000 title claims abstract description 38
- 239000007902 hard capsule Substances 0.000 title claims abstract description 16
- 239000002775 capsule Substances 0.000 claims abstract description 108
- 239000003814 drug Substances 0.000 abstract description 36
- 210000002784 stomach Anatomy 0.000 abstract description 14
- 230000001225 therapeutic effect Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 230000007794 irritation Effects 0.000 abstract description 5
- 239000011241 protective layer Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The utility model relates to the technical field of capsules, in particular to a hard capsule with a gastric mucosa protecting function, which comprises the following components: the capsule comprises a capsule outer shell and a capsule inner shell, wherein the capsule inner shell is arranged in the capsule outer shell, and a containing cavity is arranged between the outer surface of the capsule inner shell and the inner surface of the capsule outer shell; the capsule also comprises a hollow-out retainer, wherein the outer surface of the capsule inner shell is connected with the inner surface of the capsule outer shell through the hollow-out retainer. In the way, the hard capsule with the function of protecting the gastric mucosa is filled in the accommodating cavity, the medicine with the therapeutic effect is filled in the inner shell of the capsule, and the medicine with the function of protecting the gastric mucosa is positioned at the outer side of the inner shell of the capsule because the medicine with the function of protecting the gastric mucosa in the accommodating cavity is released to form a protective layer on the gastric mucosa, so that the irritation of the medicine with the therapeutic effect to the stomach is reduced, the side effect is reduced, and the health of a human body is facilitated.
Description
Technical Field
The utility model relates to the technical field of capsules, in particular to a hard capsule with a gastric mucosa protecting function.
Background
The hard capsule is also called hollow capsule, and consists of two parts of cap body, and the medicine filled in the capsule is powder or granule which has irritation to esophagus and gastric mucosa, or has bad taste, is easy to volatilize, is easy to be decomposed by saliva in oral cavity and is easy to be inhaled into trachea. The medicines are filled into capsules, so that the medicine property is not destroyed, and the digestive organs and respiratory tract are also protected. Removing the capsule shell may result in loss of the drug, waste of the drug, and reduced efficacy. The medicine refers to a capsule made of special film-forming materials (such as gelatin, cellulose, polysaccharide, etc.), and the content (such as powdery and liquid medicines, etc.) or the capsule is filled into the capsule according to dosage, so that the capsule is convenient to swallow.
Aiming at the related technology, the inventor finds that when a plurality of capsules with larger irritation are taken, the capsules enter the stomach, the caps of the capsules are dissolved to release the medicine in the stomach, and the medicine generates stronger irritation to gastric mucosa, so that the capsules have larger side effects and are not beneficial to the health of human bodies.
Disclosure of Invention
The utility model mainly solves the technical problem of providing the hard capsule with the function of protecting gastric mucosa, wherein the medicine capable of protecting the gastric mucosa is filled in the accommodating cavity, and the medicine with the therapeutic effect is filled in the inner shell of the capsule.
In order to solve the technical problems, the utility model adopts a technical scheme that: there is provided a hard capsule having a function of protecting gastric mucosa, comprising: the capsule comprises a capsule outer shell and a capsule inner shell, wherein the capsule inner shell is arranged in the capsule outer shell, and a containing cavity is arranged between the outer surface of the capsule inner shell and the inner surface of the capsule outer shell;
the capsule also comprises a hollow-out retainer, wherein the outer surface of the capsule inner shell is connected with the inner surface of the capsule outer shell through the hollow-out retainer.
Through adopting above-mentioned technical scheme, pack into the medicine that has the therapeutic effect in the capsule inner shell to put into the capsule shell with fretwork holder, then promote the capsule inner shell and get into fretwork holder in, make capsule shell and the relative fixed of capsule inner shell, at this moment, to hold the medicine that can protect the gastric mucosa of intracavity input, after swallowing the capsule, the capsule gets into the stomach, because the capsule shell is located the outside of capsule inner shell, make the stomach dissolve capsule shell earlier after, release the medicine that can protect the gastric mucosa to the stomach and form the protective layer to the gastric mucosa, thereby reduced the irritation of medicine to the stomach that has the therapeutic effect, be favorable to human health.
The present utility model may be further configured in a preferred example to: the capsule outer shell comprises a first outer shell and a second outer shell which is clamped at an opening of the first outer shell, and the length of the first outer shell is larger than that of the second outer shell.
By adopting the technical scheme, the gap is formed between the inner wall of the first outer shell and the inner shell of the capsule, so that medicines capable of protecting gastric mucosa can be conveniently filled into the gap, and more medicines capable of protecting gastric mucosa can be filled into the gap because the length of the first outer shell is longer than that of the second outer shell.
The present utility model may be further configured in a preferred example to: the capsule inner shell comprises an inner shell I and an inner shell II which is clamped with the opening of the inner shell I, and the length of the inner shell I is larger than that of the inner shell II.
By adopting the technical scheme, the medicine with the therapeutic effect is filled into the first inner shell, and then the second inner shell is clamped with the opening of the first inner shell to form a sealing effect.
The present utility model may be further configured in a preferred example to: the outer surface of the first shell body close to the opening is connected with a limiting ring, the cross section of the limiting ring is a right triangle, the outer diameter of the limiting ring is equal to that of the second shell body, and the end face of the limiting ring is in contact with the end face of the second shell body.
Through adopting above-mentioned technical scheme, through the use of spacing ring, have spacing effect to outer casing two, prevent outer casing two to continue the removal.
The present utility model may be further configured in a preferred example to: the hollowed-out retainer comprises a cylinder and a plurality of J-shaped plates connected with the outer circular surface of the cylinder in an annular array.
Through adopting above-mentioned technical scheme, the outer side of J shaped board and the inner wall contact of capsule shell body play radial support spacing effect, and capsule shell body and capsule inner shell body are fixed in radial direction promptly.
The present utility model may be further configured in a preferred example to: the hollow-out type retainer comprises an axial limiting cylinder and a plurality of radial supporting rods, wherein the axial limiting cylinder is connected to one end of the capsule inner shell, and the radial supporting rods are connected to the outer circular surface of the capsule inner shell at intervals.
Through adopting above-mentioned technical scheme, through the support spacing effect of radial bracing piece, make capsule shell body and capsule inner shell body fixed in radial direction, through the use of the spacing cylinder of axial, make the capsule inner shell body reach spacing purpose in axial direction.
In summary, the present utility model includes at least one of the following beneficial technical effects:
after the capsule is swallowed, the capsule outer shell is positioned at the outer side of the capsule inner shell, so that the stomach firstly dissolves the capsule outer shell and then releases the medicine capable of protecting the gastric mucosa to the stomach to form a protective layer on the gastric mucosa, thereby reducing the stimulation of the medicine with therapeutic effect to the stomach and being beneficial to the health of human bodies.
Drawings
For a clearer description of the technical solutions of the embodiments of the present utility model, the drawings that are needed in the description of the embodiments will be briefly introduced below, it being obvious that the drawings in the description below are only some embodiments of the present utility model, and that other drawings can be obtained according to these drawings without inventive effort for a person skilled in the art, wherein:
FIG. 1 is a schematic diagram of a hard capsule with gastric mucosa protecting function according to a preferred embodiment of the present utility model.
Fig. 2 is a schematic structural view of the hollow-out type cage in fig. 1.
FIG. 3 is a schematic view showing the structure of another preferred embodiment of a hard capsule with gastric mucosa protecting function according to the present utility model.
In the figure: 10. a capsule outer shell; 20. an inner capsule shell; 3. a receiving chamber; 40. a hollow-out cage; 5. a limiting ring;
11. an outer shell I; 12. an outer shell II;
21. an inner housing I; 22. an inner shell II;
41. a cylinder; 42. a J-shaped plate; 43. an axial limit column; 44. and (5) radial supporting rods.
Detailed Description
The preferred embodiments of the present utility model will be described below with reference to the accompanying drawings, it being understood that the preferred embodiments described herein are for illustration and explanation of the present utility model only, and are not intended to limit the present utility model.
The drawings are simplified schematic views, and only the basic structure of the present utility model is schematically described, so that only the constitution related to the present utility model is shown.
Example 1:
referring to fig. 1, a hard capsule with gastric mucosa protecting function according to the present utility model comprises: the capsule comprises a capsule outer shell 10 and a capsule inner shell 20, wherein the capsule inner shell 20 is arranged inside the capsule outer shell 10, and a containing cavity 3 is arranged between the outer surface of the capsule inner shell 20 and the inner surface of the capsule outer shell 10; the capsule outer shell 10 comprises an outer shell 11 and an outer shell 12 which is clamped at an opening of the outer shell 11, the length of the outer shell 11 is larger than that of the outer shell 12, so that more medicaments capable of protecting gastric mucosa can be filled in the accommodating cavity 3, the capsule inner shell 20 comprises an inner shell 21 and an inner shell 22 which is clamped at an opening of the inner shell 21, and the length of the inner shell 21 is larger than that of the inner shell 22, so that more medicaments with therapeutic effects can be filled in the inner shell 21.
Referring to fig. 1, a first outer shell 11 is connected with a limiting ring 5 near the opening, the first outer shell 11 and the limiting ring 5 are integrally manufactured, the cross section of the limiting ring 5 is in a right triangle shape, the outer diameter of the limiting ring 5 is equal to that of a second outer shell 12, the outer circular surface of the first outer shell 11 and the outer circular surface of the second outer shell 12 are smooth and excessive, the end face of the limiting ring 5 is in contact with the end face of the second outer shell 12, the second outer shell 12 is prevented from moving continuously through the effect of the limiting ring 5, and the limiting ring 5 plays a limiting role on the second outer shell 12.
Referring to fig. 2, the outer surface of the capsule inner housing 20 is connected with the inner surface of the capsule outer housing 10 through the hollow-out type retainer 40, the hollow-out type retainer 40 comprises a cylinder 41 and a plurality of annular J-shaped plates 42 connected on the outer circular surface of the cylinder 41 in an array manner, the outer side edges of the J-shaped plates 42 are in contact with the inner surface of the outer housing 11, the inner side edges of the J-shaped plates 42 are in contact with the outer surface of the inner housing 21, one end of the cylinder 41 is in contact with one end of the inner housing 21, the other end of the cylinder 41 is in contact with one end of the inner cavity of the outer housing 11, so that the capsule outer housing 10 and the capsule inner housing 20 are relatively fixed, and the hollow-out type retainer 40, the capsule outer housing 10 and the capsule inner housing 20 are the same in material.
The implementation principle of the embodiment 1 is as follows: the capsule inner shell 20 is filled with a medicament with a therapeutic effect, the hollowed-out retainer 40 is placed in the capsule outer shell, then the inner shell 21 on the capsule inner shell 20 is pushed into the hollowed-out retainer 40, the inner side edge of the radial supporting rod 44 is contacted with the outer surface of the inner shell 21, so that the capsule outer shell 10 and the capsule inner shell 20 are relatively fixed, at the moment, a proper amount of medicament capable of protecting gastric mucosa is put into the accommodating cavity 3, the outer shell 12 is clamped in the opening of the outer shell 11 in a sealing way, after the capsule is swallowed, the capsule enters the stomach, the medicament capable of protecting gastric mucosa is released to the stomach to form a protective layer on the gastric mucosa after the capsule outer shell 10 is firstly dissolved in the stomach, then the medicament with the therapeutic effect is released by the stomach redissolved capsule inner shell 20, so that the stimulating effect of the medicament with the therapeutic effect on the human body is reduced, the medicament capable of protecting gastric mucosa is beneficial to health of the human body, the part of protecting gastric mucosa in the accommodating cavity 3 is distributed between adjacent J42, and the other part of the medicament capable of protecting gastric mucosa is located around the cylinder 41.
Example 2:
referring to fig. 3, the difference between this embodiment and embodiment 1 is that the hollow-out type retainer 40 includes an axial limiting cylinder 43 and a plurality of radial supporting rods 44, the axial limiting cylinder 43 is connected to one end of the capsule inner shell 20, the radial supporting rods 44 are connected to the outer circumferential surface of the capsule inner shell 20 at intervals, the outer ends of the radial supporting rods 44 are in contact with the inner surface of the outer shell 11, one end of the axial limiting cylinder 43 is in contact with one end of the inner shell 21, and the other end of the axial limiting cylinder 43 is in contact with one end of the inner cavity of the outer shell 11, so that the capsule outer shell 10 and the capsule inner shell 20 are relatively fixed, and the hollow-out type retainer 40, the capsule outer shell 10 and the capsule inner shell 20 are made of the same material.
The implementation principle of the embodiment 2 is as follows: when the medicine capable of protecting the gastric mucosa is filled, a part of the medicine capable of protecting the gastric mucosa in the housing chamber 3 is distributed around the axial limit cylinder 43, and another part of the medicine capable of protecting the gastric mucosa is distributed around the radial support rod 44.
The foregoing description is only illustrative of the present utility model and is not intended to limit the scope of the utility model, and all equivalent structures or equivalent processes or direct or indirect application in other related arts are included in the scope of the present utility model.
Claims (5)
1. A hard capsule having a gastric mucosa protecting function, comprising: the capsule comprises a capsule outer shell (10) and a capsule inner shell (20), wherein the capsule inner shell (20) is arranged inside the capsule outer shell (10), and a containing cavity (3) is arranged between the outer surface of the capsule inner shell (20) and the inner surface of the capsule outer shell (10);
the capsule also comprises a hollow-out retainer (40), wherein the outer surface of the capsule inner shell (20) is connected with the inner surface of the capsule outer shell (10) through the hollow-out retainer (40);
the hollowed-out retainer (40) comprises a cylinder (41) and a plurality of J-shaped plates (42) connected with the outer circular surface of the cylinder (41) in a ring-shaped array.
2. The hard capsule with gastric mucosa protecting function according to claim 1, wherein the capsule outer shell (10) comprises an outer shell one (11) and an outer shell two (12) clamped at an opening of the outer shell one (11), and the length of the outer shell one (11) is greater than the length of the outer shell two (12).
3. The hard capsule with gastric mucosa protecting function according to claim 1, wherein the capsule inner shell (20) comprises an inner shell one (21) and an inner shell two (22) which is clamped with an opening of the inner shell one (21), and the length of the inner shell one (21) is larger than that of the inner shell two (22).
4. The hard capsule with the gastric mucosa protecting function according to claim 2, wherein the outer surface of the first outer shell (11) close to the opening is connected with a limiting ring (5), the cross section of the limiting ring (5) is a right triangle, the outer diameter of the limiting ring (5) is equal to the outer diameter of the second outer shell (12), and the end surface of the limiting ring (5) is in contact with the end surface of the second outer shell (12).
5. The hard capsule with gastric mucosa protecting function according to claim 1, wherein the hollowed-out retainer (40) comprises an axial limiting cylinder (43) and a plurality of radial supporting rods (44), the axial limiting cylinder (43) is connected to one end of the capsule inner shell (20), and the radial supporting rods (44) are connected to the outer circular surface of the capsule inner shell (20) at intervals.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321225054.9U CN220293854U (en) | 2023-05-19 | 2023-05-19 | Hard capsule with gastric mucosa protecting function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321225054.9U CN220293854U (en) | 2023-05-19 | 2023-05-19 | Hard capsule with gastric mucosa protecting function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN220293854U true CN220293854U (en) | 2024-01-05 |
Family
ID=89347960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202321225054.9U Active CN220293854U (en) | 2023-05-19 | 2023-05-19 | Hard capsule with gastric mucosa protecting function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN220293854U (en) |
-
2023
- 2023-05-19 CN CN202321225054.9U patent/CN220293854U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bechgaard et al. | Controlled-release multiple-units and single-unit doses a literature review | |
| EP1251832B1 (en) | Shell-and-core dosage form approaching zero-order drug release | |
| RU2101010C1 (en) | Taste ibuprofen masking with polymer coating | |
| DE69322077D1 (en) | ORAL PHARMACEUTICAL FORMS BASED ON HYDROXYETHYL CELLULOSE WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES | |
| FI914765A0 (en) | FREQUENTIAL ORAL MEDICINE FORM. | |
| AU672754B2 (en) | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor | |
| ATE357231T1 (en) | FUNCTIONAL COATING OF LINEZOLIDE MICRO CAPSULES FOR TASTE MASKING AND ASSOCIATED ORAL MEDICINAL PREPARATION | |
| CN102008392B (en) | Preparation with accurate dose-dividing function | |
| BRPI0711503A2 (en) | SHEET SHEET DOSAGE FORM FOR PHARMACEUTICAL PREPARATION, USE OF A COMBINATION OF ACTIVE AGENTS AND METHOD FOR THE THERAPEUTIC TREATMENT OF AN INDIVIDUAL | |
| CN220293854U (en) | Hard capsule with gastric mucosa protecting function | |
| FI20000780A7 (en) | Oral dosage form for controlled release of the drug | |
| Mortensen et al. | Oesophageal obstruction from a pharmacobezoar resulting in death | |
| JP2008543851A (en) | Emetic capsules | |
| CN215022729U (en) | Capsule with three-layer structure | |
| CN119139260A (en) | Aspirin-containing pharmaceutical preparation and preparation method and application thereof | |
| CN219354715U (en) | Hard capsule | |
| Wells et al. | Bezoar Formation Requiring Endoscopic Removal After Intentional Overdose of Extended‐Release Nifedipine | |
| CZ356696A3 (en) | Support of active compounds for their controlled release in gastrointestinal tract with delayed passage through pylorus | |
| KR20220128387A (en) | Swallowable devices for drug delivery in the intestinal tract | |
| CN219022343U (en) | Hard capsule | |
| CN219354688U (en) | Hard capsule convenient to swallow | |
| US12337067B2 (en) | Oral medicine delivery capsule | |
| JP3233036U (en) | Liversol tablets with sustained release capsule structure | |
| US9101546B2 (en) | Capsule for encapsulating a tablet | |
| GB2162061A (en) | Controlled time release therapeutic composition having means for counteracting overdosage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |